Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2897588 Title: MEDICAMENT INHALABLE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
148092489
WO application number:
US2014066872
Type:
European patent granted for BE
Status:
Open
Publication number:
2897588
WO publication number:
WO2015077594
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/11/2014
Grant date:
17/07/2019
EP publication date:
29/07/2015
WO publication date:
28/05/2015
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
17/07/2019
EP B1 publication date:
17/07/2019
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/11/2034

Applicant

Name:
Teva Branded Pharmaceutical Products R&D, Inc.
Legal Form:
From:
17/07/2019
Address:
41 Moores Road, Frazer PA 19355, United States (US)
To:

Agent

Name:
LAENEN Bart
Legal Form:
From:
19/09/2019
Address:
Kempische Steenweg 542A, 3500, HASSELT, Limburg, Belgium (BE)
To:

Inventor

1

Name:
DALVI, Mukui
Legal Form:
Address:
Miami, FL 33169, United States (US)

2

Name:
WU, Libo
Legal Form:
Address:
Miami, FL 33169, United States (US)

Priority

Priority patent number:
201361907782 P
Priority date:
22/11/2013
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2019/22
Publication date:
21/08/2019
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
201929
Publication date:
17/07/2019
Description:
Grant (B1)

2

Issue number:
202012
Publication date:
18/03/2020
Description:
Opposition procedure started

3

Issue number:
202215
Publication date:
13/04/2022
Description:
Opposition rejected; Patent maintained as granted

Annual fee

Annual fee(s) Due Date:
01/12/2025
Annual fee number:
12
Annual fee amount:
240 Euro
Expected payer:
Last annual fee payment date:
22/10/2024
Last annual fee paid number:
11
Last annual fee paid amount:
215 Euro
Payer:
ANAQUA SERVICES
Filing date Document type Publication Type Document Description Number of pages File Type
19/09/2019 Outgoing Correspondence 1 PDF /5/1/8/9/7/0721879815/docs/148092489_0_outgoingcorrespondence_20190920_082056570.pdf
19/09/2019 Incoming Correspondence (Email) Cover letter 1 PDF /5/1/8/9/7/0721879815/docs/148092489_1_incomingcorrespondenceelectronic_20190920_082057999.pdf
04/07/2023 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /5/1/8/9/7/0721879815/docs/148092489_2_rfc_20230706_111012284.pdf
19/09/2019 Incoming Correspondence (Email) Cover letter 2 PDF /5/1/8/9/7/0721879815/docs/148092489_3_incomingcorrespondenceelectronic_20190920_082057057.pdf